Trial Profile
Parallel Randomised Open Phase II Study of Oxaliplatin (L-OHP) Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Locally Advanced or Metastatic Endometrial Cancer Previously Treated With Cisplatin or Carboplatin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2010
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil
- Indications Endometrial cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 26 Feb 2008 New trial record.